Evidence map›Paper›PMID 34848414›Full record

ArticleBMJ case reports2021

Topiramate-induced severe electrolyte abnormalities and hypernatremia leading to central pontine myelinolysis.

Luba Muaddi, Omar Osman, Barbara Clark

Open access · hybridAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Luba MuaddiDepartment of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA barbara.clark@ahn.org luba.muaddi@ahn.org.
Omar OsmanDepartment of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Barbara ClarkDepartment of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA barbara.clark@ahn.org luba.muaddi@ahn.org.ORCID http://orcid.org/0000-0002-6696-1424
Allegheny Health Network · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central pontine myelinolysis (CPM) develops due to acute hypernatremia from a normal baseline serum sodium in the setting of electrolyte abnormalities induced by topiramate use. Topiramate is a commonly used medication with several indications including migraines, myoclonic jerks and seizures. It has been reported to cause renal tubular acidosis and severe electrolyte abnormalities, which in turn predispose patients to neuropathology via renal concentration defects and osmotic shifts. Our patient is a 55-year-old woman with a history of multiple sclerosis and myoclonus on topiramate for several years who presented with weakness and was found to be profoundly hypokalemic. She went on to develop changes in mental status, motor deficits and evidence of CPM on MRI during her hospitalisation. Surprisingly, the patient never had hyponatremia; however, she had an acute rise in serum sodium from a normal baseline after fluid resuscitation with normal saline for hypotension during her admission.

Indexed as

HypernatremiaHyponatremiaMyelinolysis, Central PontineElectrolytesFemaleHumansMagnetic Resonance ImagingMiddle AgedTopiramateElectrolytesTopiramatefluid electrolyte and acid-base disturbancesneuroimagingpsychiatry (drugs and medicines)renal system

Identifiers

PMID34848414
PMCPMC8634286
OpenAlexW3214964624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.